Facilitated By

San Antonio Medical Foundation

News

  • Biothera Pharmaceuticals Phase 2 Triple Negative Breast Cancer Data Selected for Spotlight ...

    ... Selected for Spotlight Session at San Antonio Breast Cancer Symposium ... Biothera Pharmaceuticals is a privately held biotechnology company ...

  • Foundation Medicine Expands Indication for FoundationOne®CDx as a Companion Diagnostic for ...

    ... presenting new data at this year's San Antonio Breast Cancer Symposium (SABCS) highlighting the ... INDUSTRY KEYWORD: ONCOLOGY HEALTH FDA GENETICS GENERAL HEALTH PHARMACEUTICAL BIOTECHNOLOGY.

  • New Yorker gets 40 years in prison for supporting Hezbollah

    Authorities said Kourani came to the U.S. legally in 2003, earning a bachelor's degree in biomedical engineering in 2009 and a master's degree in ...

  • Coworking plans aim to breathe new life into old buildings

    “DRTC does shiny-object entrepreneurship,” Lamoureux said. “We're not going to do biotech. We're going to do website design.” Online: https://bit.ly/ ...

  • Cook Medical Hemospray® Receives the 2019 Healio Disruptive Innovators Award

    ... of Gastroenterology Annual Scientific Meeting in San Antonio, Texas. ... MEDICAL DEVICES SURGERY RESEARCH SCIENCE BIOTECHNOLOGY.